Omneity® Pellets
All-In-One Vitamin & Mineral Pellet
Topic:Insulin
Insulin is a hormone produced by the pancreas that plays a pivotal role in regulating glucose metabolism in horses. It facilitates the uptake of glucose by cells, thus maintaining blood sugar levels within a normal range. Insulin's function is integral to energy balance and metabolic processes in equines. Disruptions in insulin regulation can lead to metabolic disorders such as Equine Metabolic Syndrome (EMS), characterized by insulin resistance and associated with obesity and laminitis. This page aggregates peer-reviewed research studies and scholarly articles that explore the physiological role, regulatory mechanisms, and clinical implications of insulin in equine health and disease management.
The Effect of Seasonal Changes in Non-Structural Carbohydrates in Pasture on the Metabolic Profile of Horses with Laminitis. This study aimed to examine the seasonal dynamics of non-structural carbohydrates in pasture and their relationship to metabolic indicators in horses with a history of laminitis. Thirty Hucul mares were divided into a laminitis group (LG, = 15) and a control group (CG, = 15). Insulin, glucose, fructosamines concentrations and body weight were monitored during four sampling periods (S0-S3), while pasture variables were analyzed during three periods (S1-S3). The concentration of water-soluble carbohydrates was highest in May (126.8 g/kg DM) and measured lower in October (57.9 g/kg DM), while s...
Effects of total parenteral nutrition and electrolyte solutions with or without glutamine on the hormonal profiles of horses subjected to exploratory laparotomy. Starvation and nutritional support clinically influence horses, particularly during the treatment of gastrointestinal diseases and post-surgical recovery. In this study, we aimed to evaluate the effects of different nutritional strategies on the endocrine response of horses subjected to exploratory laparotomy followed by food deprivation. Sixteen healthy adult horses were randomly allocated into four groups (n=4) based on treatments: enteral fluid therapy without (ENTFL) or with glutamine (ENTGL), and parenteral fluid therapy with glucose (PARFL) or total parenteral nutrition with glutamine (P...
Sodium-glucose transporters SGLT1 and SGLT2 in equine renal, hepatic and pancreatic tissue. Insulin dysregulation is a hallmark of equine metabolic syndrome (EMS), and in recent years, pharmacological treatment with sodium-dependent glucose transporter 2 inhibitors (SGLT2i) have shown promise in reducing the risk of hyperinsulinemia-associated laminitis in horses diagnosed with EMS. In humans and laboratory animals, this transporter protein is responsible for the majority of renal tubular glucose reabsorption, however, the presence of this and the related sodium-dependent glucose transporter 1 (SGLT1) have not yet been studied in equine kidneys. Additionally, studies in humans and la...
Intra-articular methylprednisolone acetate does not induce hyperinsulinemia or hyperglycemia in metabolically normal horses. The goal of this project was to examine the metabolic effects of IA methylprednisolone acetate (MPA) following injection into multiple low-motion joints. Unassigned: Six 3-year-old geldings without pituitary pars intermedia dysfunction or insulin dysregulation were randomly injected with 20 mg of IA MPA/joint (80 mg total; bilateral distal hock joints) or an equal volume of saline. Serial blood samples were collected for resting ACTH, cortisol, insulin, and glucose, as well as insulin and glucose following repeated low-dose oral sugar tests. Treatments were crossed over after a 6-week washout,...
Leucine, pyridoxine and resveratrol supplementation alter metabolic parameters in ponies with equine metabolic syndrome. Supplements claiming to improve metabolic profiles in equine metabolic syndrome (EMS) often lack scientific validation. Objective: To evaluate the effect of a supplement containing leucine, resveratrol and pyridoxine on the metabolic profile in ponies with EMS. Methods: Unmasked randomised, placebo-controlled field trial. Methods: Thirty-eight ponies completed the trial across five farms. Ponies were age and sex matched per farm and randomly assigned to the supplement (n = 20) or placebo group (n = 18) with owners masked to group assignments. Ponies were sampled at days -1/0 (T1), 7/8 ...
Bile acids segregate metabolic syndrome in a cohort of 100 deeply phenotyped horses. Metabolic syndrome (MetS)-encompassing obesity, insulin resistance, dyslipidemia, and hypertension-is prevalent in both humans and horses, offering a unique opportunity to explore shared pathophysiological mechanisms across species in a controlled model organism. In this first report from the Pioneer 100 Horse Health Project (P100HHP), we conducted a longitudinal, multi-omic analysis of 108 deeply phenotyped horses to interrogate individual health trajectories for precision insights into MetS. We identified two primary metabotypes: one characterized by elevated unsaturated triglycerides (TGs) ...
Forage Carbohydrate Profiles and Endocrine Morphometric Interactions in Traditionally Managed Horses from Romania. Horses maintained under traditional management systems and dependent on natural forages are often exposed to seasonal and compositional variations that can affect metabolic homeostasis. This study examined associations between forage nutrient composition and metabolic-morphometric indicators in horses from four agroecologically distinct regions of northwestern Romania. Eighty-eight horses managed under semi-extensive rural conditions underwent clinical examination, body condition scoring (BCS), cresty neck scoring (CNS), and fasting blood sampling. Forage samples ( = 34) from daily rations wer...
Revitalizing equine metabolism: how SHBG improves mitochondrial function and reduces inflammation. Equine metabolic syndrome (EMS) is associated with chronic low-grade inflammation, disruptions in mitochondrial dynamics and function, and an increased risk of developing laminitis. Recent research has highlighted that reduced levels of sex hormone-binding globulin (SHBG) in the bloodstream are linked to higher susceptibility to obesity, insulin resistance, and diabetes, potentially contributing to broader metabolic imbalances. This study aimed to evaluate whether exogenously administered SHBG could protect adipose-derived stem cells from horses affected by EMS (EqASC) against mitochondrial dy...
Abnormal Fetuin-A levels in obese horses are associated with activated TLR4/NF-ƙB/MAPK axis and depleted FBXW7 E3 ubiquitin ligase. Fetuin-A (FetA) is a multifactorial glycoprotein primarily synthesized by the liver with additional expression in adipose tissue, the abundance of which is tightly regulated by the FBXW7 E3 ubiquitin ligase. Recently, FetA has been implicated in the pathogenesis of insulin resistance and associated metabolic failures in humans through its potent and selective inhibition of insulin receptor tyrosine kinase activity, however, no studies have yet directly investigated its role in the development and progression of equine obesity. In this investigation, FetA levels were measured in serum, liver, a...
Effects of the Sodium-Glucose Cotransporter-2 Inhibitor Velagliflozin on Insulin Concentrations in Horses With Insulin Dysregulation. Sodium-glucose cotransporter-2 inhibitors (SGLT2i) are promising treatments to manage hyperinsulinemia in horses with insulin dysregulation (ID). Objective: The SGLT2i velagliflozin decreases insulin concentration in horses with ID. Methods: Privately-owned adult horses (n = 37) with laboratory-confirmed ID (low-dose oral sugar test insulin concentration > 75 μIU/mL). Methods: Double-blind randomized placebo-controlled trial. Horses received placebo (n = 19) or velagliflozin 0.3 mg/kg PO q24h (n = 18) for 20 weeks (Study Period 1, SP1) immediately followed by a 20-week ...
Equine Pituitary Pars Intermedia Dysfunction. Pituitary pars intermedia dysfunction (PPID) is a common, slowly progressive, neurodegenerative disorder of the older horse. Oxidative damage to the hypothalamic periventricular neurons results in loss of dopaminergic inhibition of the pars intermedia region of the pituitary gland. Consequently, there is increased production of the pro-opiomelanocortin (POMC)-derived hormones normally produced by this region, as well as initial melanocyte hypertrophy and hyperplasia, followed by adenomatous change. Clinical signs that are highly suggestive of the disease are generalised and regional hypertrich...
Investigations on metabolic diseases of horses in Egypt. Obesity is a significant risk factor that predisposes horses to laminitis, equine metabolic syndrome, arthritis, heart disease, and respiratory issues. Unassigned: Mares showing overweight or laminitis ( = 30), different BCS ( = 90) weighing 350-550 Kg were subjected to clinical and rump fat assessments. Blood samples were collected to measure circulating estradiol, progesterone, cortisol, insulin, insulin-like growth factor-1 (IGF-1), and leptin. Additionally, glucose, cholesterol, triglycerides, total proteins, albumin, nitric oxide (NO), lactate dehydrogenase (LDH), glutathione redu...
Gestation-Stage Related Changes in the IGF System Components in the Equine Placenta. The insulin-like growth factor (IGF) system regulates implantation, placental development, and angiogenesis in eutherian mammals. However, little is known about the changes in this system in equine placenta (chorioallantois; CA) and the endometrium (EN) during pregnancy, or the relationship to vascular endothelial growth factor () expression. The current study investigated the expression of the IGF system components, namely the ligands ( and ), their receptors (, , and ), and their binding proteins ( and s) in equine CA at 45 days, 4, 6, 10, and 11 months of gestational age (GA) and immediatel...
Canagliflozin: Pharmacokinetics, tolerability and glucose/insulin effects of supratherapeutic doses in healthy horses. Sodium-glucose co-transporter 2 inhibitors like canagliflozin (CFZ) have shown promise in preventing hyperinsulinemia-associated laminitis in horses, but data on pharmacokinetics, tolerability, and controlled studies are limited. This randomized, open-label, placebo-controlled, crossover study evaluated these aspects of CFZ treatment in eight healthy Standardbred mares. Each horse received single supratherapeutic oral doses of CFZ (1.8 mg/kg or 3.6 mg/kg) and placebo, with a two-week washout between treatments. A graded glucose infusion (GGI) was administered post-treatment to evaluate glu...
Clinical evaluation of the ADVIA Centaur XPT chemiluminescent immunoassay for equine insulin measurement. Insulin dysregulation is a key component of equine metabolic syndrome and is commonly assessed using basal insulin concentrations. Different analyzers may yield variable insulin results, limiting comparability. Objective: To assess the analytical performance of the ADVIA Centaur XPT chemiluminescent immunoassay (CLIA) for equine insulin measurement and to establish adapted decision thresholds based on comparison with a previously used CLIA method. Methods: Precision, linearity, and dilution recovery were assessed for the ADVIA Centaur XPT. A total of 89 equine serum samples submitted for basal...
Pioglitazone does not adequately control hyperinsulinemia but does increase serum adiponectin concentrations in equids with severe insulin dysregulation. To characterize the effects of pioglitazone (2 mg/kg, PO, either q 24 h [PIO-SID] or q 12 h [PIO-BID]) in equids with severe hyperinsulinemia. Unassigned: 17 client-owned equids with severe resting hyperinsulinemia (> 100 µIU/mL) were assigned to PIO-SID or PIO-BID in a prospective cohort study with rolling enrollment over an 11-month study period (December 13, 2022, to November 17, 2023). Basal insulin, total and high-molecular-weight adiponectin concentrations, and plasma pioglitazone concentrations were measured over 70 days. Oral sugar tests (OSTs) were performed on days 0 and 28. Resu...
Plasma Activin A concentrations are not a useful biomarker for detecting insulin dysregulation and predicting laminitis risk in ponies. Circulating insulin concentrations are used to quantify risk of laminitis in currently non-laminitic ponies. Basal serum activin A (AA) concentration has previously been positively correlated with serum insulin concentrations 60 minutes (T60) following an oral sugar test (OST) in ponies with equine metabolic syndrome. Therefore, circulating AA might be a useful marker for insulin dysregulation (ID) and laminitis risk. Objective: To explore the relationship between circulating AA concentrations at baseline (T0) and T60 in ponies that developed laminitis within six months and non-laminitic ponie...
Quantitative proteomics unveils potential plasma biomarkers and provides insights into the pathophysiological mechanisms underlying equine metabolic syndrome. Equine Metabolic Syndrome (EMS) is a multifactorial endocrine disorder characterized by obesity, insulin dysregulation (ID), and an increase in the risk of laminitis, a painful condition that can lead to euthanasia in severe cases. Diagnosing EMS is challenging and often relies on clinical history including obesity, difficulty in losing weight, and recurring episodes of laminitis. The gold standard for laboratory support of an EMS diagnosis is the identification of ID, with basal insulin being the simplest and most accessible method, especially in a field setting. However, various factors such...
The effects of a long-duration intravenous infusion of detomidine, with and without vatinoxan, on equine energy metabolism and urine composition. To assess the effects of a 4 hour detomidine constant rate infusion (CRI) with and without a vatinoxan CRI on energy metabolism and urine composition. Methods: Randomized, blinded, crossover study. Methods: Eight Finnhorses, 587 (550-620) kg [median (range)] and 13 (4-16) years old. Methods: Horses were administered an intravenous (IV) detomidine loading dose (0.01 mg kg) followed by 240 minutes CRI (0.015 mg kg hour) (DET) and the same detomidine protocol combined with an IV vatinoxan loading dose (0.15 mg kg) and CRI (0.05 mg kg hour) (DET+VAT). Blood samples for glucose, insulin, non-esteri...
Identifying insulinemic responses of ID horses offered varying levels of NSC and meal-sizes. Feeding small meals (∼1 g/kg BW DM basis) providing >10% nonstructural carbohydrates (NSC; starch + water soluble carbohydrate; WSC) has resulted in an augmented insulin response (AIR) in insulin dysregulated (ID) horses, but it’s unclear if AIR reflects NSC content or the g NSC/kg BW/meal. The insulinemic responses of ID (n = 7) and non-insulin dysregulated (NID; n = 8) horses fed four feeds (A = 6.8% NSC; B = 14.9% NSC; C = 35.5% NSC; D = 44.6% NSC) at three levels of NSC intake (0.06, 0.11-0.12 and 0.17-0.18 g/kg BW) were evaluated in a randomized Latin square design across two phas...
Markers of Hepatic Insulin Clearance and Their Association With Steatosis in Hyperinsulinaemic Horses. Hyperinsulinaemia (HI) is an important feature of Equine Metabolic Syndrome (EMS). It has been suggested that reduced hepatic clearance of insulin contributes to HI, particularly in humans affected by metabolic dysfunction-associated steatotic liver disease (MASLD). Objective: In obese horses with HI, insulin clearance is impaired and associated with MASLD. Methods: Tissue samples were collected at post-mortem from clinically well-characterized horses with HI (n = 13; basal insulin > 20 mIU/l) and without HI (control; n = 20). Methods: Retrospective observational study. Molecula...
Prevalence and Progression of Resting ACTH, Insulin and Adiponectin Values as Indicators of Suspected Endocrine Diseases in Sport Horses and Ponies Compared to Non-Sport Horses, Ponies and Donkeys. Prevalence of endocrine disease in sport horses has been sparsely reported. They often compete well into their teenage years; thus, diagnosis and control of endocrine disease could be important to maintain performance and optimise health and welfare. The aim was to compare the prevalence of pituitary pars intermedia dysfunction (PPID), insulin dysregulation (ID) and metabolic obesity between sport and non-sport type breeds and assess disease progression. Blood samples submitted for plasma adrenocorticotropic hormone (ACTH), serum insulin or adiponectin were included in this study. Horses were ...
The effect of an alpha2-adrenoceptor antagonist on equine carbohydrate metabolism after intravenous glucose load. Vatinoxan is a peripherally acting alpha2-adrenoceptor antagonist used in veterinary medicine to attenuate the side effects of alpha2-adrenoceptor agonists. Vatinoxan also increases insulin response and reduces blood glucose (BG) after intravenous glucose in other species. The aim of this study was to investigate the effects of vatinoxan on BG and insulin concentration in horses after intravenous glucose. The design was an assessor-blind cross-over study. Nine horses were assigned to intravenous vatinoxan (0.2 mg/kg; VAT) or saline (SAL). Horses were administered an intravenous glucose bolus (...
Effects of pasture consumption and obesity on insulin dysregulation and adiponectin concentrations in UK native-breed ponies. Insulin dysregulation (ID) and hypoadiponectinaemia (total [adiponectin] <7.9 μg/mL) are risk factors for laminitis. They are sometimes, but not always, associated with obesity. Objective: To investigate the effects of pasture consumption and obesity on ID and circulating total [adiponectin] in ponies. Methods: Longitudinal. Methods: Seven native-breed ponies with normal basal and post-oral sugar test (OST) [insulin] and body condition score (BCS) 4.3-5.5/9 were allowed to graze until they reached BCS 7/9. Ponies were then maintained at BCS 7/9 until completion of the study (week 22). Mo...
Aleurone supplementation enhances the metabolic benefits of training in Standardbred mares: impacts on glucose-insulin dynamics and gut microbiome composition. Aleurone, derived from the bran layer of grains like wheat and barley, has demonstrated positive effects on energy metabolism in pigs, mice, and untrained horses, influencing glucose-insulin dynamics and gut microbiome composition. Training itself enhances insulin sensitivity in horses, similar to the improvements in performance capacity observed in human athletes. This study aimed to investigate whether aleurone supplementation provides additional benefits to training by modulating insulin metabolism and gut microbiota in Standardbred mares. Unassigned: Sixteen Standardbred mares (aged 3-5 ye...
Isolation method and characterization of adipocytes as a tool for Equine Obesity Research – in vitro study. Adipose tissue functions as an endocrine organ; however, excessive lipid accumulation can lead to obesity and metabolic disorders, such as Equine Metabolic Syndrome (EMS), characterized by insulin resistance, fat deposition, and increased inflammation. Despite the growing prevalence of obesity in horses, knowledge of equine adipocytes and their metabolic functions remains limited. The main objective of the study was to develop and optimize a method for isolating equine adipocytes and to characterize their metabolic activity. Using slaughterhouse-derived horse visceral adipose tissue, we develo...
Alterations in the Vaginal Vascular Perfusion, Chromoendoscopy and Oxidative Stress in Mares With Vaginitis and Endometritis. This study aimed to demonstrate the vaginal tissue alterations via vaginal biopsy and hemodynamic alterations by introducing chromoendoscopy to analyse the effect of equine vaginitis on the oxidative and hormonal profile. Mares were divided into normal mares (N = 10) and affected mares (N = 10). Animals were subjected to Doppler ultrasonographic evaluation, endoscopic examination, oxidative stress was estimated, and biopsy samples were taken for histopathology and immunohistochemistry. Uterine body (UB) thickness (mm), circumference (mm) and area (mm) elevated significantly in infected...
Corticosteroid Administration Enhances the Glycemic, Insulinemic, and Incretin Responses to a High-Protein Mixed Meal in Adult Horses. Corticosteroids are used routinely in horses and induce insulin dysregulation (ID). Nutrition is important for ID management and includes low nonstructural carbohydrate (NSC) diets and, often, high-protein ration balancers (RB). Insulin and incretin secretion increase after high-protein meals; corticosteroids may influence these effects. Objective: A high-protein mixed meal will induce hyperinsulinemia and increased concentrations of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) in horses with ID; dexamethasone (DEX) will amplify this effect. Methods: F...
Current understanding of insulin dysregulation and its relationship with carbohydrate and protein metabolism in horses. Insulin dysregulation (ID) is a common metabolic disorder in horses, characterized by hyperinsulinemia and/or peripheral insulin resistance. The critical role of hyperinsulinemia in endocrinopathic laminitis has driven research into the insulinotropic effects of dietary nutrients and the reciprocal impact of ID on nutrient metabolism. The relationship between ID and carbohydrate metabolism has been extensively studied; however, the effects of ID on protein metabolism in horses remain largely unexplored. This review begins with an overview of the importance of insulin in the regulation of muscl...
Evaluation of an Automated Fluorescence Enzyme Immunoassay for Quantification of Equine Insulin and Comparison to Five Other Immunoassays. Hyperinsulinemia is an important and treatable risk factor for laminitis in horses. Objective: Evaluate the Tosoh AIA-360 automated fluorescence enzyme immunoassay for the measurement of serum insulin concentrations in horses, and compare it to five other immunoassays for insulin quantification. Methods: One hundred serum samples from 83 horses were submitted for insulin measurement. Methods: The Tosoh AIA-360 was assessed against a reference assay (radioactive immunoassay; RIA). Using the same samples, TOS-FEIA, ELISA, and three chemiluminescent immunoassays (CLIA) were assessed for correlati...
